Côd QR

Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence

Introduction Obesity affects over 650 million adults worldwide and is a major risk factor for cardiovascular diseases and type 2 diabetes. Among those affected are patients treated with antipsychotics, such as clozapine and olanzapine, which often lead to significant weight gain, increasing the ris...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Natalia Gniaź, Aleksandra Górska, Wiktor Grela, Jagoda Niewiadomska, Daria Furtak, Dawid Tulej, Paulina Głogowska, Alicja Dziedzic, Dominika Marciniuk, Natalia Marko
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Kazimierz Wielki University 2024-12-01
Cyfres:Journal of Education, Health and Sport
Pynciau:
obesity
antipsychotic-induced weight gain
clozapine
olanzapine
adverse effect
GLP-1 receptors agonist
Mynediad Ar-lein:https://apcz.umk.pl/JEHS/article/view/56672
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg